In a significant advancement for alternative protein technology, Israeli food-tech startup Forsea has announced a breakthrough in cell-cultivated seafood production, potentially revolutionizing the USD2bn global eel market.
The company’s proprietary organoid technology has achieved cell densities exceeding 300 million cells per milliliter—reportedly the highest in the industry—while minimizing costly growth media usage. This development could make lab-grown unagi, a premium Japanese delicacy, commercially viable for the first time.
The timing is critical. Japan, which consumes half the world’s eel supply, saw demand reach 140,000 tons in 2023. With wild eel populations endangered and commercial breeding impossible, prices have surged, straining traditional suppliers.
“This breakthrough validates our approach to high-efficiency cultivation,” said Moria Shimoni, Forsea’s Chief Technology Officer. The company’s patent-protected method allows fish cells to self-organize into three-dimensional tissues, circumventing expensive scaffolding processes that have historically made cultured meat prohibitively costly.
Earlier this year, Forsea showcased its progress at a Tel Aviv tasting event, serving cultivated unagi kabayaki to Japanese embassy officials and food industry representatives. The company plans commercial launch in 2026.
Backed by venture firms including Target Global and PeakBridge VC, Forsea represents a new wave of food-tech companies targeting premium seafood products. Success in the eel market could provide a template for scaling other cultivated seafood products.
Industry analysts note that achieving price parity with traditional seafood remains crucial for market adoption. Forsea’s technological advances suggest this hurdle might be overcome sooner than expected, though regulatory approval in key markets like Japan and the US will be essential for commercialization.
Find out more at: https://www.forseafoods.com/